Electrical Impedance Scanning for the Early Detection of Breast Cancer in Young Women

Currently, no established method exists for screening young, pre-menopausal women for breast cancer. Electrical Impedance Scanning (EIS), an innovative breast screening technology, appears to identify women at increased risk for breast cancer. A multi-center trial in the North Atlantic Region has be...

Full description

Bibliographic Details
Main Author: Stojadinovic, Alexander
Other Authors: HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE ROCKVILLE MD
Format: Text
Language:English
Published: 2006
Subjects:
Anatomy and Physiology
Medicine and Medical Research
Electricity and Magnetism
*ELECTRICAL IMPEDANCE
*BREAST CANCER
*CANCER SCREENING
SCANNING
MILITARY PERSONNEL
WOMEN
MAMMOGRAPHY
MAGNETIC RESONANCE IMAGING
MAMMARY GLANDS
RISK
DIAGNOSIS(MEDICINE)
EIS(ELECTRICAL IMPEDANCE IMAGING)
North Atlantic
Online Access:http://www.dtic.mil/docs/citations/ADA451340
http://oai.dtic.mil/oai/oai?&verb=getRecord&metadataPrefix=html&identifier=ADA451340
Description
Summary:Currently, no established method exists for screening young, pre-menopausal women for breast cancer. Electrical Impedance Scanning (EIS), an innovative breast screening technology, appears to identify women at increased risk for breast cancer. A multi-center trial in the North Atlantic Region has been initiated in an effort to extend the potential benefit of this new technology to active-duty service members and young female healthcare beneficiaries with the aim of acquiring the data necessary to determine the feasibility of the EIS system, T-Scan" 2000ED as a breast cancer risk identifying/screening tool in young women. Women age 30 to 45 underwent EIS with routine clinical breast examination. EIS+ women were referred for further diagnostic breast imaging and breast biopsy, if indicated. 1,385 women were studied. Three women had a high risk or cancerous tumour of the breast; one was T-Scan positive. Of the 1,382 with benign findings, 1,285 were T-Scan negative. Thus, our interim results are consistent with an earlier validation trial showing that a T-Scan positive woman is six times more likely to have a high-risk lesions or cancer (~1 in 100) than a T-Scan negative women (~1 in 600). Continuation of the present multi-center trial is warranted to confirm that EIS can identify young women at increased risk for breast cancer, those most likely to benefit from more diligent surveillance, early breast imaging, and risk reduction intervention.

Similar Items